Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2012
04/25/2012EP2089356B1 Salt of aliskiren with orotic acid
04/25/2012EP1014953B1 Formulations for hydrophobic pharmaceutical agents
04/25/2012CN102427813A Novel anti-inflammatory agents
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101735155B 一锅法合成2-嘧啶氧基苄基取代苯基胺类衍生物的方法 One-Pot Synthesis of 2-benzyl substituted phenyl pyrimidine amine derivative method
04/25/2012CN101495452B Ep2激动剂 Ep2 agonists
04/25/2012CN101265235B 除草剂双草醚的制备方法 Preparation of Bispyribac
04/24/2012US8163926 Process for the synthesis of piperidinyl sulphonate esters
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163745 HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163287 Combination therapy of her expressing tumors
04/24/2012US8161969 Dry powder dispersing apparatus and methods for their use
04/24/2012CA2481926C Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha.4 integrins
04/19/2012WO2012051036A1 Quinazolinone-type compounds as crth2 antagonists
04/19/2012WO2012050371A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
04/19/2012WO2012050347A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
04/19/2012WO2012050264A1 Novel seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them
04/19/2012WO2012050041A1 Aryloxyurea compound and pest control agent
04/19/2012WO2012049192A1 Ipp complex as marker for erlotinib treatment
04/19/2012WO2012015168A3 Pharmaceutical composition comprising rosuvastatin or a pharmaceutically acceptable salt thereof
04/19/2012US20120095230 Process for the preparation of pyrimidine derivatives
04/19/2012US20120095229 Chemical process
04/19/2012US20120095228 Method for the preparation of erlotinib
04/19/2012US20120095227 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
04/19/2012US20120095220 Continuous Method For Producing Amides Of Aliphatic Carboxylic Acids
04/19/2012US20120095031 Cyclopropane compound
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095011 Novel compounds
04/19/2012US20120094999 Egfr inhibitors and methods of treating disorders
04/19/2012US20120094998 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
04/19/2012US20120094997 Substituted hydroxamic acids and uses thereof
04/19/2012US20120094983 Acyclic ikur inhibitors
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012CA2813908A1 Aryloxyurea compound and pest control agent
04/19/2012CA2813279A1 Ipp complex as marker for erlotinib treatment
04/18/2012EP2440534A2 Pyrimidine derivatives as zap-70 inhibitors
04/18/2012EP2440533A1 Guanine riboswitch binding compounds and their use as antibiotics
04/18/2012EP2440528A1 Heterocyclic antiviral compounds
04/18/2012EP2440048A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
04/18/2012EP2247579B1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
04/18/2012EP2177512B1 Inhibitor of binding of s1p1
04/18/2012EP2176238B1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
04/18/2012CN1956966B Quinazoline derivatives and therapeutic use thereof
04/18/2012CN102421762A Substituted pyrimidines for the treatment of cancer
04/18/2012CN102421761A 二氨基杂环甲酰胺化合物 Diamino heterocyclic carboxamide compound
04/18/2012CN102421760A Dihydropyrimidinones for use as bace2 inhibitors
04/18/2012CN102421739A 羧酸化合物 Carboxylic acid compound
04/18/2012CN101935304B 瑞舒伐他汀甘氨酸叔丁酯盐及其制备方法 Rosuvastatin glycine tert-butyl ester salts and its preparation method
04/18/2012CN101838270B Intermediates of Entecavir and preparation thereof
04/18/2012CN101798289B 一种埃罗替尼中间体的制备方法 Preparation method of erlotinib intermediates
04/18/2012CN101182311B New method for removing benzyl from quinazoline molecules containing halogens
04/18/2012CN101177414B 抗癌化合物zd1839的新晶形、其制备方法及含该晶形的药用组合物 The new crystalline form of the anticancer compound zd1839, its preparation method and a pharmaceutical composition containing the crystalline form of
04/17/2012US8158820 Compounds
04/17/2012US8158787 Process for producing trichloropyrimidine compound
04/17/2012US8158642 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
04/17/2012US8158641 2-anilino-4-aminoalkyleneaminopyrimidines
04/17/2012US8158640 Tetrahydroquinoline derivatives and a process for preparing the same
04/17/2012US8158639 Non-sedating barbiturate compounds as neuroprotective agents
04/17/2012US8158637 Sodium channel moderators; antiarrhythmia agents; analgesics; antiarthritic agents; antiinflammatory agents; antieplipetic agents; psychological disorders; nervous system disorders
04/17/2012US8158607 Crystalline form of lamivudine
04/17/2012CA2599328C Quinazoline derivative having tyrosine kinase inhibitory activity
04/17/2012CA2516589C Hiv replication inhibiting pyrimidines and triazines
04/17/2012CA2468948C Preventives or remedies for alzheimer's disease or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
04/12/2012WO2012048222A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS
04/12/2012WO2012046681A1 Agent for inhibiting expression of lipid metabolism related mrna
04/12/2012WO2012046207A1 Anti-parasitic substituted ring fused azine compounds
04/12/2012WO2012046193A1 New salt of a pyrimidin derivative
04/12/2012WO2012046132A1 Quinazoline compounds as sodium channel blockers
04/12/2012US20120088914 Production method of pyrimidine compounds
04/12/2012US20120088911 Novel carboxylic acid derivatives, their preparation and use
04/12/2012US20120088782 Lpa receptor antagonist
04/12/2012US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
04/12/2012CA2813704A1 Quinazoline compounds as sodium channel blockers
04/12/2012CA2813388A1 New salt of a pyrimidin derivative
04/11/2012EP2439203A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/11/2012EP2439199A1 E-type phenyl acrylic ester compounds containing substituted anilino pyrimidine group and uses thereof
04/11/2012EP2439198A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
04/11/2012EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
04/11/2012EP2125754B1 Process for preparation of rosuvastatin calcium
04/11/2012EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance
04/11/2012EP1261590B1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
04/11/2012CN102414177A Compounds as bradykinin b1 antagonists
04/11/2012CN102414170A Insecticidal compounds
04/11/2012CN102414168A 用作为alx受体和/或fprl2激动剂的桥联螺[2.4]庚烷衍生物 Alx used as receptors and / or agonists fprl2 bridged spiro [2.4] heptane derivatives
04/11/2012CN102413841A 鱼类寄生虫驱除方法 Fish antiparasitic method
04/11/2012CN102408382A 一种制备长效磺胺药物的方法 The method of preparation of a long-acting sulfonamides
04/11/2012CN102408381A 抗感染药物的制备方法 Preparation of anti-infective drugs
04/11/2012CN102408380A 5-氨基嘧啶硫酮类化合物及其制备方法 5-amino-pyrimidine Thiones its preparation method
04/11/2012CN102408379A 磺胺-6-甲氧嘧啶的制备方法 Sulfa -6-methoxy pyrimidine method
04/11/2012CN102408378A 一种5-氰基嘧啶的合成方法 A method of synthesis of 5-cyano-pyrimidine
04/11/2012CN101798288B Method for purifying pyrimidine compounds
04/10/2012US8153843 Antibacterial agents
04/10/2012US8153791 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions
04/10/2012US8153790 Process for the preparation and purification of etravirine and intermediates thereof
04/10/2012US8153655 Compositions useful as inhibitors of voltage-gated sodium channels
04/10/2012US8153644 Diacylglycerol acyltransferase inhibitors
04/10/2012US8153642 Quinazolines useful as modulators of ion channels
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 427